INS and Hyperglycemia: The ability of CypD to control glucose homeostasis and insulin production in vivo (this work) should be considered in therapeutic strategies aimed at targeting CypD for neurodegeneration24, ischemia-reperfusion injury22, 23 and possibly hyperglycemia.